31 December 2019 - Global Hair Loss
& Growth Treatment Market is
anticipated to witness an exponential growth in the forecast period. The
factors that propel the growth of the market include changing lifestyle and
exposure to the environment, technological advancement of laser hair, increased
hair loss problems and aging population, rising disposable income and increased
demand for natural products.
On
the other hand, there are factors that may hamper the growth of the market
including Laser Hair Treatment and OTC Drugs, lack of awareness and high cost
or treatment. Hair loss & growth treatment market is anticipated to expand
at a significant CAGR in the upcoming period as the scope, product types, and
its applications are increasing across the globe.
Market
could be explored by product type, type, application, end user, distribution
channel and geography. Market by product type spans Procapil, Minoxidil, and
Others. Based on type, the hair loss & growth treatment market comprises
Shampoos and Conditioners, Hair Loss and Growth Devices and Medicine Product. The
“Medicine Product” segment led the market in 2017 and is anticipated to
maintain its dominance by 2023.
The
key applications that could be explored in the hair loss & growth treatment
market include Men, Children and Women. The “Women” segment led the market in
2017 and is anticipated to maintain its dominance by 2023. The market could be
explored based on end user as Home hold and Commercial. The “Home hold” segment
led the market in 2017 and is anticipated to maintain its dominance by 2023.
The key factor that may be attributed to the growth of market includes rising
demand.
The
market could be explored based on distribution channel as Direct Sales, and
Distributor. The “Direct sales” segment led the market in 2017 and is
anticipated to maintain its dominance by 2023.
North
America accounted for the major share of the market in 2017 and will continue
to lead in the forecast period. The factors attributed to the growth include
technological advancement in the region, increased aged population in the developed
regions, consumers, particularly women looking for safe and natural products
instead of going for laser hair treatment and increasing environmental
pollution. North America is followed by Asia-Pacific region.
Some
of the key players that fuel the growth of the hair loss & growth treatment
market comprise Taisho Pharma, J&J, Merck, Wal-Mart, Costco Wholesale,
Zhejiang Wan sheng Pharma, Bayer, Zhendong Anter, Sichuan Medco Huakang Pharma,
Renata, DrFormulas, DS Healthcare Group and Dr.R. PFLEGER. The leading
companies are taking up partnerships, mergers and acquisitions, and joint
ventures in order to boost the inorganic growth of the industry.
Market Segment:
Geographically, this report is segmented
into several key Regions, with production, consumption, revenue (million USD),
market share and growth rate of Hair Loss & growth Treatment in these
regions, from 2012 to 2023 (forecast), covering
•
North America (United States, Canada and Mexico)
•
Europe (Germany, France, UK, Russia and Italy)
•
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
•
South America (Brazil, Argentina, Columbia)
•
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Hair Loss & growth Treatment
market competition by top manufacturers, with production, price, revenue
(value) and market share for each manufacturer; the top players including
•
Procter & Gamble
•
L'Oreal
•
Unilever
•
Taisho
•
Henkel
•
Merck
•
Shiseido
•
Johnson & Johnson Consumer Inc.
•
Rohto
•
Lifes2Good
•
Gerolymatos International
•
Toppik
•
Nanogen
•
Oxford BioLabs Ltd.
•
Ultrax Labs
On the basis of product, this report
displays the production, revenue, price, market share and growth rate of each
type, primarily split into
•
Hair Loss and Growth Devices
•
Shampoos and Conditioners
•
Medicine Product
Comments
Post a Comment